The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Alekseeva T.M.

Almazov National Medical Research Centre

Isabekova P.S.

Almazov National Medical Research Centre

Kondratova E.I.

Almazov National Medical Research Centre

Abdulina L.U.

Almazov National Medical Research Centre

New pathogenic treatments for myasthenia gravis

Authors:

Alekseeva T.M., Isabekova P.S., Kondratova E.I., Abdulina L.U.

More about the authors

Views: 971

Downloaded: 4


To cite this article:

Alekseeva TM, Isabekova PS, Kondratova EI, Abdulina LU. New pathogenic treatments for myasthenia gravis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;125(1):31‑38. (In Russ.)
https://doi.org/10.17116/jnevro202512501131

Recommended articles:
Expe­rience of using eculizumab in refractory myasthenia gravis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7-2):85-90
Clinical and epidemiological characteristics of myasthenia in the Altai region. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):198-202
Robo­tic and thoracoscopic surgeries for ante­rior mediastinal neoplasms. Piro­gov Russian Journal of Surgery. 2025;(2):6-12

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.